MOUNTAIN VIEW, Calif., Oct. 1 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of FlexFiber(TM) a laser fiber probe intended for effective delivery of laser energy during ear, nose and throat (ENT) procedures. Introduced at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting and Oto Expo, this consumable product represents an increase in IRIDEX' presence in the ENT market, providing physicians with additional clinical applications and expanded treatment offerings.
"The addition of the FlexFiber probe will expand the utilization of the IRIDEX OcuLight TX laser consoles currently used to perform otology procedures," commented Theodore A. Boutacoff, President & CEO. "The FlexFiber probe diversifies IRIDEX' product offering in this ever-expanding ENT market."
FlexFiber is intended for the delivery of laser energy during ENT procedures. It is indicated for, but not limited to, incision, excision, coagulation, and vaporization of soft and fibrous tissue, including osseous tissue. Features include:
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.
SOURCE IRIDEX Corporation
|SOURCE IRIDEX Corporation|
Copyright©2009 PR Newswire.
All rights reserved